Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 2/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4074456 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL17813049 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL19426268 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL14282838 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL23485849 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL8531995 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL24398891 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL8529263 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL2361 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 | |
| SCHEMBL8625934 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1USP2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 38159 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075399-A | Formula of exosome skin medicament and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026104273-A1 | COSMETIC COMPOSITION COMPRISING A CATIONIC INULIN, A GLUCAMIDE AND AN ANIONIC SURFACTANT, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2026-05-21 | — | — | WO | claimed |
| US-20260132159-A1 | GOLD CONTAINING COMPOUNDS AND METHODS OF USE | UNIV OF KENTUCKY RESEARCH FOUNDATION (US) | 2026-05-14 | — | — | US | claimed |
| US-12559704-B2 | Microelectronic device cleaning composition | ENTEGRIS, INC. (US) | 2026-02-24 | — | — | US | claimed |
| US-20260021118-A1 | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | REMEDY PHARMACEUTICALS, INC. (US) | 2026-01-22 | — | — | US | claimed |
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-12-25 | — | — | US | claimed |
| EP-4667483-A1 | HUMAN TRANSFERRIN RECEPTOR-BINDING PEPTIDE | JCR Pharmaceuticals Co., Ltd. (JP) | 2025-12-24 | — | — | EP | claimed |
| US-20250345347-A1 | METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA | REMEDY PHARMACEUTICALS, INC. (US) | 2025-11-13 | — | — | US | claimed |
| US-20250262227-A1 | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | REMEDY PHARMACEUTICALS, INC. (US) | 2025-08-21 | — | — | US | claimed |
| US-12350365-B2 | Products and methods for reducing malodor from the pudendum | WELLS FARGO BANK, N.A. | 2025-07-08 | — | — | US | claimed |
| EP-0002228-B1 | HYDROXY NAPHTHOQUINONE DERIVATIVES, THEIR PREPARATIONS FOR TREATING AND PREVENTING THEILERIOSIS IN CATTLE AND SHEEP, PROCESSES FOR THEIR SYNTHESIS; NAPHTHOQUINONE DERIVATIVES | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-02-29 | — | — | EP | claimed |
| EP-0098135-A2 | Solubilized platinum(II) complexes | ENGELHARD CORPORATION (US) | 1984-01-11 | — | — | EP | claimed |
| EP-0095901-A1 | Process for the preparation of (d) 2-(d-methoxy-2-naphthyl) propionic acid and pharmaceutically acceptable salts thereof and new intermediates therefor | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1983-12-07 | — | — | EP | claimed |
| US-4375542-A | ANTIACNE, ANTITUMOR, ANTIMALARIAL, ANTIBACTERIAL, AND ANTIINFLAMMATORY AGENT | SCHERING CORPORATION (US) | 1983-03-01 | — | — | US | claimed |
| US-4297100-A | Aqueous dye preparations | CIBA-GEIGY CORPORATION (US) | 1981-10-27 | — | — | US | claimed |
| EP-0002228-A2 | Hydroxy naphthoquinone derivatives, their preparations for treating and preventing theileriosis in cattle and sheep, processes for their synthesis; naphthoquinone derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1979-06-13 | — | — | EP | claimed |
| US-4137302-A | ACETYL-UREA SOLUBILIZED BY N-METHYL GLUCAMINE | LEVER BROTHERS COMPANY (US) | 1979-01-30 | — | — | US | claimed |
| US-3958004-A | ADMINISTERING | MERCK & CO., INC. (US) | 1976-05-18 | — | — | US | claimed |
| US-3937733-A | X-RAY CONTRAST AGENTS | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-02-10 | — | — | US | claimed |
| US-3932439-A | N-substituted cycloserine compounds, salts thereof, and processes for preparing them | MERCK & CO., INC. (US) | 1976-01-13 | — | — | US | claimed |